PeerVoice Endocrinology & Metabolic Disorders Audio

By PeerVoice

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

  1. 1.
    A Multidisciplinary Approach to Prevention and Management of CKD in T2DM: Best Practices for Optimal Outcomes
    28:53
  2. 2.
    Understanding the Impact of Gene Fusion Detection in NSCLC: The Latest Updates on Testing and Treatment Strategies
    15:40
  3. 3.
    The Holistic Care of Patients with T2DM: Going Beyond HbA1c
    23:07
  4. 4.
    Clinical Conundrums in Type 2 Diabetes: Managing Challenging Cases in Primary Care
    25:47
  5. 5.
    Optimising Use of Traditional Oral Glucose-Lowering Therapies in Type 2 Diabetes: Important for Patients and Society!
    17:07
  6. 6.
    Treatment Gaps in T2DM and Obesity: Personalising Care for Better Outcomes
    31:27
  7. 7.
    Personalising Care Across the Disease Continuum: From Prediabetes Through Type 2 Diabetes
    44:02
  8. 8.
    Evaluating the Evidence for SGLT2 Inhibition in CKD: Highlights From the 2021 Virtual ERA-EDTA Congress
    8:39
  1. 9.
    Evaluating the Evidence for Managing CKD: Highlights From World Congress of Nephrology 2021
    8:44
  2. 10.
    Step-by-Step: Setting a Course for Long-Term Control of Type 2 Diabetes With GLP-1 RAs
    21:16
  3. 11.
    Why Combination Therapies and Why Now? The Rationale and Role of GLP-1 RAs and Insulin
    32:52
  4. 12.
    "Setting New Goals for Slowing Progression in Chronic Kidney Disease: What Is Possible With GLP-1 RAs?"
    39:04
  5. 13.
    Could PSMA Be the ‘Bulls-Eye’ Target in mCRPC?
    18:59
  6. 14.
    Stroke Prevention, Type 2 Diabetes, and GLP-1 Receptor Agonists: What Neurologists Need to Know
    44:48
  7. 15.
    Modern Management of Chronic Kidney Disease: A Look to the Future
    10:33
  8. 16.
    SGLT2 Inhibition for HF: Evidence From Virtual Scientific Sessions 2020
    37:43
  9. 17.
    Evaluating the Evidence for SGLT2 Inhibition in CKD: Highlights of Kidney Week 2020
    10:13
  10. 18.
    Novel Strategies for Chronic Kidney Disease: New Data, New Paradigm?
    21:51
  11. 19.
    Modern Management of Chronic Kidney Disease: A Look to the Future
    15:04
  12. 20.
    Breaking the Cycle of Severe Hypoglycemia in Diabetes: Educating Clinicians and Patients Alike
    20:38
  13. 21.
    New Targets in Heart Failure: Congress Updates on SGLT2 Inhibitors
    12:32
  14. 22.
    Evaluating the Evidence for SGLT2 Inhibition in CKD
    19:42
  15. 23.
    Halting the Cascade of Chronic Kidney Disease: Can We Catch Patients Before They Fall?
    36:03
  16. 24.
    Managing Youth-Onset Type 2 Diabetes: What Paediatricians Need to Know
    19:47
  17. 25.
    Hiding in Plain Sight: Identifying Patients at Risk for NASH
    24:34
  18. 26.
    Managing Complicated Cases in Type 2 Diabetes
    14:24
  19. 27.
    Imagining a World Without Hepatitis C Virus: A Call to Action
    10:03
  20. 28.
    Heart Matters in T2DM: The Experts Weigh In
    25:39
  21. 29.
    Managing Lipid-Related Cardiovascular Risk: What We Know Now
    19:23
  22. 30.
    Setting a Path for Success in Type 2 Diabetes: What We Know Now
    1:11:20
  23. 31.
    Warming Up to Novel Approaches for Primary Cold Agglutinin Disease: Strategies for Correct Diagnosis and Optimal Treatment
    16:08
  24. 32.
    Evaluating the Latest Data in Ulcerative Colitis
    17:29
  25. 33.
    PARP Inhibitors for Ovarian Cancer: Making the Right Choices at the Right Times
    9:52
  26. 34.
    Getting at the Heart of Comprehensive Disease Control in Type 2 Diabetes: What’s New?
    1:17:18
  27. 35.
    A Closer Look at Safety of Glucose-Lowering Therapy
    18:46
  28. 36.
    Improving Outcomes in Type 2 Diabetes: Focus on Cardiovascular and Renal Safety
    1:13:39
  29. 37.
    Ticking All the Boxes: A Multidisciplinary Approach to Hidradenitis Suppurativa
    1:10:30
  30. 38.
    Considering the Possibility of Psoriatic Arthritis in Patients With Psoriasis
    16:02
  31. 39.
    Cardiovascular and Renal Safety in Type 2 Diabetes: What Clinicians Need to Know
    20:44

Listen to PeerVoice Endocrinology & Metabolic Disorders Audio now.

Listen to PeerVoice Endocrinology & Metabolic Disorders Audio in full in the Spotify app